Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
6.90
2.49 (56.46%)
At close: Oct 03, 2025, 3:59 PM
7.11
3.04%
Pre-market: Oct 06, 2025, 07:57 AM EDT
56.46% (1D)
| Bid | 6.83 |
| Market Cap | 186.81M |
| Revenue (ttm) | 394K |
| Net Income (ttm) | -64.86M |
| EPS (ttm) | -2.46 |
| PE Ratio (ttm) | -2.8 |
| Forward PE | -1.76 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.94 |
| Volume | 61,426,001 |
| Avg. Volume (20D) | 100,207 |
| Open | 4.76 |
| Previous Close | 4.41 |
| Day's Range | 4.72 - 8.45 |
| 52-Week Range | 1.60 - 15.04 |
| Beta | 2.02 |
| Ex-Dividend Date | n/a |
About ANRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+25.56%
Alto Neuroscience shares are trading higher after ...
Unlock content with
Pro Subscription
11 months ago
-69.99%
Alto Neuroscience shares are trading lower after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.
1 month ago · businesswire.com
Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANROLOS ANGELES--(BUSINESS WIRE)---- $ANRO--Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANRO.